# FDA Inspection 1102523 - Cade Medical, Inc. - September 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/cade-medical-inc/e6c4d69a-7d83-4b67-a123-bd840ddb4074
Source feed: FDA_Inspections

> FDA Inspection 1102523 for Cade Medical, Inc. on September 18, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102523
- Company Name: Cade Medical, Inc.
- Inspection Date: 2019-09-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1247881 - 2024-08-30](https://www.keypedia.com/records/fda_inspections/cade-medical-inc/7097d581-292d-4429-8f2f-e658f570714f)
- [FDA Inspection 1003866 - 2016-12-29](https://www.keypedia.com/records/fda_inspections/cade-medical-inc/8c6b24d9-7366-4db0-ac03-b346130c9d9b)

Company: https://www.keypedia.com/companies/cade-medical-inc/8a004c19-2a5b-4944-b2ca-14a037b04a44

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d